These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 7543174

  • 1. Bcl-2 protein expression in normal human bone marrow precursors and in acute myelogenous leukemia.
    Porwit-MacDonald A, Ivory K, Wilkinson S, Wheatley K, Wong L, Janossy G.
    Leukemia; 1995 Jul; 9(7):1191-8. PubMed ID: 7543174
    [Abstract] [Full Text] [Related]

  • 2. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
    Graf M, Hecht K, Reif S, Pelka-Fleischer R, Pfister K, Schmetzer H.
    Eur J Haematol; 2004 Feb; 72(2):89-106. PubMed ID: 14962246
    [Abstract] [Full Text] [Related]

  • 3. Differential expression of BCL-2 oncoprotein and Fas antigen on normal peripheral blood and leukemic bone marrow cells. A flow cytometric analysis.
    Molica S, Mannella A, Dattilo A, Levato D, Iuliano F, Peta A, Consarino C, Magro S.
    Haematologica; 1996 Feb; 81(4):302-9. PubMed ID: 8870373
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. High expression of urokinase plasminogen activator receptor (UPA-R) in acute myeloid leukemia (AML) is associated with worse prognosis.
    Graf M, Reif S, Hecht K, Pelka-Fleischer R, Pfister K, Schmetzer H.
    Am J Hematol; 2005 May; 79(1):26-35. PubMed ID: 15849776
    [Abstract] [Full Text] [Related]

  • 6. Expression of poliovirus receptor-related proteins PRR1 and PRR2 in acute myeloid leukemia: first report of surface marker analysis, contribution to diagnosis, prognosis and implications for future therapeutical strategies.
    Graf M, Reif S, Hecht K, Kroell T, Nuessler V, Schmetzer H.
    Eur J Haematol; 2005 Dec; 75(6):477-84. PubMed ID: 16313259
    [Abstract] [Full Text] [Related]

  • 7. Changes in phenotype and proliferative potential of human acute myeloblastic leukemia cells in culture with stem cell factor.
    Ikeda H, Kanakura Y, Furitsu T, Kitayama H, Sugahara H, Nishiura T, Karasuno T, Tomiyama Y, Yamatodani A, Kanayama Y.
    Exp Hematol; 1993 Dec; 21(13):1686-94. PubMed ID: 7694869
    [Abstract] [Full Text] [Related]

  • 8. Comparative quantitative expression of bcl-2 by normal and leukaemic myeloid cells.
    Bradbury DA, Russell NH.
    Br J Haematol; 1995 Oct; 91(2):374-9. PubMed ID: 8547078
    [Abstract] [Full Text] [Related]

  • 9. Multiparametric analysis of apoptotic and multi-drug resistance phenotypes according to the blast cell maturation stage in elderly patients with acute myeloid leukemia.
    Suárez L, Vidriales B, García-Laraña J, López A, Martínez R, Martín-Reina V, Tormo M, González-San Miguel JD, Lavilla E, García-Boyero R, Orfao A, San Miguel JF, PETHEMA Cooperative Group.
    Haematologica; 2001 Dec; 86(12):1287-95. PubMed ID: 11726321
    [Abstract] [Full Text] [Related]

  • 10. Combined analysis of bcl-2 and MDR1 proteins in 256 cases of acute myeloid leukemia.
    Venditti A, Del Poeta G, Maurillo L, Buccisano F, Del Principe MI, Mazzone C, Tamburini A, Cox C, Panetta P, Neri B, Ottaviani L, Amadori S.
    Haematologica; 2004 Aug; 89(8):934-9. PubMed ID: 15339676
    [Abstract] [Full Text] [Related]

  • 11. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia.
    Zeleznikova T, Stevulova L, Kovarikova A, Babusikova O.
    Neoplasma; 2007 Aug; 54(6):471-7. PubMed ID: 17949229
    [Abstract] [Full Text] [Related]

  • 12. Differences between the CD34+ and CD34- blast compartments in apoptosis resistance in acute myeloid leukemia.
    van Stijn A, van der Pol MA, Kok A, Bontje PM, Roemen GM, Beelen RH, Ossenkoppele GJ, Schuurhuis GJ.
    Haematologica; 2003 May; 88(5):497-508. PubMed ID: 12745269
    [Abstract] [Full Text] [Related]

  • 13. Induction of death (CD95/FAS), activation and adhesion (CD54) molecules on blast cells of acute myelogenous leukemias by TNF-alpha and IFN-gamma.
    Munker R, Andreeff M.
    Cytokines Mol Ther; 1996 Sep; 2(3):147-59. PubMed ID: 9384699
    [Abstract] [Full Text] [Related]

  • 14. Immunological classification of acute myeloblastic leukemias: relevance to patient outcome.
    Casasnovas RO, Slimane FK, Garand R, Faure GC, Campos L, Deneys V, Bernier M, Falkenrodt A, Lecalvez G, Maynadié M, Béné MC.
    Leukemia; 2003 Mar; 17(3):515-27. PubMed ID: 12646939
    [Abstract] [Full Text] [Related]

  • 15. Expression of the c-fgr and hck protein-tyrosine kinases in acute myeloid leukemic blasts is associated with early commitment and differentiation events in the monocytic and granulocytic lineages.
    Willman CL, Stewart CC, Longacre TL, Head DR, Habbersett R, Ziegler SF, Perlmutter RM.
    Blood; 1991 Feb 15; 77(4):726-34. PubMed ID: 1825181
    [Abstract] [Full Text] [Related]

  • 16. Triple immunofluorescence evaluation of CD15, CD34 and class II expression by flow cytometry in normal and leukemic bone marrows.
    Venditti A, Del Poeta G, Stasi R, De Fabriitis P, Coppetelli U, Bruno A, Simone MD, Papa G.
    Haematologica; 1993 Feb 15; 78(6):359-63. PubMed ID: 7513673
    [Abstract] [Full Text] [Related]

  • 17. Candidate hematopoietic stem cells from fetal tissues, umbilical cord blood vs. adult bone marrow and mobilized peripheral blood.
    Huang S, Law P, Young D, Ho AD.
    Exp Hematol; 1998 Nov 15; 26(12):1162-71. PubMed ID: 9808056
    [Abstract] [Full Text] [Related]

  • 18. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry.
    Rezaei A, Adib M, Mokarian F, Tebianian M, Nassiri R.
    Med Sci Monit; 2003 Aug 15; 9(8):CR359-62. PubMed ID: 12942032
    [Abstract] [Full Text] [Related]

  • 19. Regulation of Bcl-2 expression and apoptosis in acute myeloblastic leukaemia cells by granulocyte-macrophage colony-stimulating factor.
    Bradbury D, Zhu YM, Russell N.
    Leukemia; 1994 May 15; 8(5):786-91. PubMed ID: 8182935
    [Abstract] [Full Text] [Related]

  • 20. Contrasting antigenic maturation patterns in M0-M2 versus M3 acute myeloid leukemias.
    Lewis RE, Cruse JM, Webb RN, Sanders CM, Beason K.
    Exp Mol Pathol; 2007 Oct 15; 83(2):269-73. PubMed ID: 17603036
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.